In a phase III trial, Libtayo (cemiplimab) demonstrated a significant improvement in overall survival in women with advanced cervical cancer after progression on chemotherapy, reducing the risk of death by 31% compared to chemotherapy in the overall population.
Vanderbilt researchers found that people with a high polygenic risk score for colorectal cancer could benefit more at preventing the disease by leading healthy lifestyles than those at lower genetic risk.
Researchers at MD Anderson Cancer Center have developed a first-of-its-kind spatial atlas of early-stage lung cancer and surrounding normal lung tissue at single-cell resolution, providing a resource for studying tumor development and identifying new therapeutic targets.
Treatment guided by molecular imaging technology invented and developed by researchers at Winship Cancer Institute of Emory University shows improved disease-free survival rates for men who have undergone surgical removal of their prostate.
A research team has designed a molecule with potential to interfere in a new way with altered proteins that cause abnormal growth in 35% of pancreatic cancers.
In his first address to a joint session of Congress April 28, President Joe Biden made a pitch for significantly increasing federal funding for biomedical research, especially cancer research—a cornerstone of his jobs plan.
Researchers, patient advocates, and global oncology leaders who have worked to reshape cancer care around the world are among the recipients of the American Society of Clinical Oncology’s Special Awards—the society’s highest honors—and the Women Who Conquer Cancer Mentorship Awards from Conquer Cancer, the ASCO Foundation.
The National Academy of Sciences announced the election of 120 members. Of the new members 59 are women, the most elected in a single year.
St. Jude Children’s Research Hospital plans to invest $11.5 billion over the next six years to accelerate research and treatment globally for children with catastrophic diseases.
Gabriel Seidman was named director of policy within the new Policy Department at The Lawrence J. Ellison Institute for Transformative Medicine of USC.
